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The increased presence of chemical contaminants in the environment is an undeniable
concern to human health and ecosystems. Historically, by relying heavily upon costly
and laborious animal-based toxicity assays, the field of toxicology has often neglected
examinations of the cellular and molecular mechanisms of toxicity for the majority of
compounds—information that, if available, would strengthen risk assessment analyses.
Functional toxicology, where cells or organisms with gene deletions or depleted proteins
are used to assess genetic requirements for chemical tolerance, can advance the field of
toxicity testing by contributing data regarding chemical mechanisms of toxicity. Functional
toxicology can be accomplished using available genetic tools in yeasts, other fungi and
bacteria, and eukaryotes of increased complexity, including zebrafish, fruit flies, rodents,
and human cell lines. Underscored is the value of using less complex systems such
as yeasts to direct further studies in more complex systems such as human cell lines.
Functional techniques can yield (1) novel insights into chemical toxicity; (2) pathways and
mechanisms deserving of further study; and (3) candidate human toxicant susceptibility or
resistance genes.
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CHEMICAL PRODUCTION AND ITS IMPLICATIONS
Current estimates project that global chemical production—
currently growing 3% per year—will double every 25 years
(Wilson et al., 2006). In the United States alone, excluding
fuels, pesticides, pharmaceuticals, or food products, about 42 bil-
lion pounds of chemicals are produced or imported daily (U.S.
EPA, 2005). Many chemicals are managed through the Toxic
Substances Control Act (TSCA), but several independent anal-
yses have concluded that these regulations seriously hinder (1)
toxicity testing and hazard assessment; (2) control of chemi-
cals of concern; and (3) investment in safer alternatives, such as
those generated by the tenets of green chemistry (Wilson and
Schwarzman, 2009). Combined with the widespread use and
distribution of industrial chemicals, the data and safety gaps pre-
cipitated by TSCA elicit a situation in which chemical exposures
to humans and ecosystems are oftentimes of unknown hazard
and risk.
THE PRESENT STATE OF CHEMICAL TOXICITY TESTING
The field of toxicology currently employs extensive animal-based
assays to evaluate chemical toxicity, a burdensome and pro-
hibitively expensive approach that typically assesses a limited
number of endpoints. Considering that tens of thousands of in
use chemicals lack adequate toxicity data (Judson et al., 2009),
it is unreasonable to rely upon these traditional methods to fill
data gaps. The National Research Council (NRC), realizing that
more innovative approaches to testing were needed, envisioned
that toxicology should commit to mechanistically-based high-
throughput cellular in vitro assays (NRC, 2007; Andersen and
Krewski, 2010). In this way, a more complete comprehension
of chemical toxicity can be achieved, while expediting testing,
decreasing costs, and reducing animal usage.
Although high-throughput in vitro methods certainly signal
progress in toxicity testing, they are limited to existing assays
with known endpoints, such as analyses of stress response path-
ways induced by oxidative species, heat shock, DNA damage,
hypoxia, and unfolded proteins (Simmons et al., 2009). Another
approach utilizes “omics” technologies such as gene expression
profiling, proteomics, lipidomics, and metabolomics to conduct
targeted and untargeted investigations into chemical mechanisms
of toxicity (reviewed by Hamadeh et al., 2002; Gatzidou et al.,
2007). However, by associating toxicant exposure with changes in
mRNA, protein, lipid, or metabolite levels, these assays are cor-
relative and do not provide direct links between genes and their
requirements in the cellular toxicant response.
THE ADVANTAGES OF FUNCTIONAL TOXICOLOGY
Functional toxicology is based in the high-throughput use of
cells/organisms harboring gene deletions or depleted proteins to
systematically examine genetic requirements for toxicity toler-
ance. Any assayable phenotype can be measured in response to
a toxicant, but viability or fitness are the most conventional end-
points (Figure 1). Functional techniques can provide information
distinct from the aforementioned correlative methodologies; for
example, Giaever et al. (2002) found that expression of a gene is
generally unrelated to its requirement for growth under a selec-
tive condition. Functional analyses, which have been conducted
in budding and fission yeast (Table 1), bacteria, nematodes, fruit
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FIGURE 1 | The concept of functional toxicology in yeast. In this
example, a yeast cell with the PDR5 gene is able to survive under toxicant
selection, whereas a cell deleted for PDR5 experiences susceptibility to
that same toxicant. Therefore, the PDR5 gene is essential for survival in
that toxicant.
flies, zebrafish, and human cell lines (Table 2), can (1) contribute
novel insight into chemical mechanisms of action; (2) define
more specific toxicological endpoints; and (3) inform further
mechanistic-based assays.
FUNCTIONAL TOXICOLOGY IN YEASTS
For many reasons, the eukaryotic budding (Saccharomyces
cerevisiae) and fission (Schizosaccharomyces pombe) yeasts are
ideal models in which to conduct functional toxicological studies.
Numerous metabolic and signaling pathways, along with basic
cellular processes, are conserved with more complex organisms
such as humans. Human homologs have been identified for
a large number of yeast genes, with several hundred of the
conserved genes linked to disease in humans (Steinmetz et al.,
2002; Wood et al., 2002). A long history of genetic manipulation
in yeasts confers the ability to selectively target and examine
conserved genes and pathways throughout their genomes, facil-
itating functional analyses. The ease of culture and availability
of software resources, molecular protocols, and genetic and
physical interaction data collectively bolster the value of yeasts in
toxicology.
Barcoded mutant collections have been generated in budding
(Giaever et al., 1999, 2002) and fission yeast (Kennedy et al., 2008;
Kim et al., 2010; Chen et al., 2012), allowing assessment of indi-
vidual strain fitness in pooled cultures under selective conditions
(reviewed by North and Vulpe, 2010; dos Santos et al., 2012). This
technique, known as functional profiling, functional genomics,
chemical genomics, or chemical-genetic profiling, can identify
the genetic requirements for tolerance to any substance that
causes measurable growth inhibition in yeast. Figure 2 demon-
strates the screening process, whileTable 1 provides a summary of
recent functional studies. Homozygous profiling (HOP) utilizes
strains deleted for non-essential genes to establish the genetic
requirements for chemical tolerance, while haploinsufficiency
profiling (HIP) detects strains sensitized to a chemical targeting
the product of their corresponding heterozygous locus (for a
review, see Smith et al., 2010a). In brief, DNA sequences (“bar-
codes”) uniquely identifying each deletion strain enable parallel
growth analyses with thousands of pooled mutants exposed to
a chemical of interest. A PCR amplification of the barcodes and
their subsequent quantification via microarray hybridization or
sequencing allows for discovery of strains with altered growth
in the particular substance. The decreased abundance by mRNA
perturbation (dAMP) collection complements heterozygote pro-
filing by destabilizing a gene’s mRNA (and thus depleting the
encoded protein) via disruption of 3′-untranslated regions (Yan
et al., 2008). An additional tool that may benefit functional tox-
icology is the barcoded yeast overexpression library (Ho et al.,
2009; Douglas et al., 2012). Similar to HOP and HIP, this tech-
nique enables highly parallel and systematic investigations of
overexpression phenotypes in pooled cultures. Finally, a novel
“functional variomics” approach utilizes high-complexity ran-
dommutagenesis to identify genes conferring drug resistance due
to mutations or overexpression (Huang et al., 2013a). The advent
of multiplexed high-throughput barcode sequencing of pooled
cultures (Han et al., 2010; Smith et al., 2010b) promises a future
of expedited and cost efficient functional genomic analyses.
The functional tools available in yeast provide unmatched
resources for inquiries into potential cellular and molecular
mechanisms of toxicity. Such analyses have informed functional
experimentation in more complex organisms such as zebrafish
or human cell lines. For example, Ishizaki et al. (2010) utilized a
yeast chemical-genetic screen to reveal that intracellular traffick-
ing defects conferred sensitivity to copper limitation, and further
reported that knockdown of zebrafish homologs to these yeast
genes sensitized fish to copper-dependent hypopigmentation,
a hallmark of copper deficiency in humans. Following identifi-
cation of the Sas2p histone acetyltransferase as a modulator of
arsenite tolerance in yeast, knockdown of its homolog MYST1
in human bladder epithelial cells was found to similarly induce
arsenite sensitivity (Jo et al., 2009a,b). Another group demon-
strated that the investigational cancer drug elesclomol affected
electron transport mutants in yeast and extended their analysis
by determining that elesclomol interacted with the electron
transport chain in human cells (Blackman et al., 2012). Likewise,
a functional screen in yeast identified mitochondrial translation
inhibition as the lethality mechanism of the antimicrobial
and antileukemic compound tigecycline, and this activity was
confirmed in leukemic cells (Skrtic´ et al., 2011). Finally, Jo
et al. (2009a) used yeast to show that a S-adenosylmethionine
dependent methyltransferase conferred resistance to various
arsenic species, while Ren et al. (2011) showed the corresponding
gene in humans (N6AMT1) could metabolize arsenic in human
urothelial cells. Harari et al. (2013) expanded upon these studies
by demonstrating that N6AMT1 polymorphisms were associated
with arsenic methylation in Andean women, and posited that
the polymorphisms could be used as susceptibility markers for
arsenic toxicity.
POTENTIAL FOR FUNCTIONAL TOXICOLOGY IN OTHER
FUNGI AND BACTERIA
The recent development of the TagModule collection (Oh et al.,
2010a), building upon the work of Xu et al. (2007), takes
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Table 1 | Summary of recent functional toxicological screens in
yeasts.
Chemical class Description Organism References
Solvents Butanol
Dimethylsulfoxide
Dimethylsulfoxide
S. cerevisiae
S. cerevisiae
S. cerevisiae
González-Ramos
et al., 2013
Zhang et al., 2013
Gaytán et al., 2013a
Metals Aluminum
Gold nanoparticles
Cobalt
Cadmium
S. cerevisiae
S. cerevisiae
S. pombe
S. pombe
Tun et al., 2013
Smith et al., 2013
Ryuko et al., 2012
Kennedy et al., 2008
Persistent
pollutants
Dieldrin
Toxaphene
S. cerevisiae
S. cerevisiae
Gaytán et al., 2013b
Gaytán et al., 2013c
Antimicrobials 2,4-diacetylphloro-
glucinol
Antimicrobial
peptides
Curcumin
Chitosan
Eugenol
Thymol
Polyalkyl
guanidiniums
TA-289
Micafungin
Various antifungals
S. cerevisiae
S. cerevisiae
S. cerevisiae
S. cerevisiae
S. cerevisiae
S. cerevisiae
S. cerevisiae
S. cerevisiae
S. pombe
S. pombe
Troppens et al., 2013
Lis et al., 2013
Azad et al., 2013
Galván Márquez
et al., 2013
Darvishi et al., 2013a
Darvishi et al., 2013b
Bowie et al., 2013
Quek et al., 2013
Zhou et al., 2013
Fang et al., 2012
Drugs Chloroquine
Edelfosine
Porphyrin TMpyP4
FK506
Caffeine
S. cerevisiae
S. cerevisiae
S. cerevisiae
S. pombe
S. pombe
Islahudin et al., 2013
Cuesta-Marbán et al.,
2013
Andrew et al., 2013
Ma et al., 2011
Calvo et al., 2009
Genotoxicants Methyl
methanesulfonate
Various
Various
Various
S. cerevisiae
S. cerevisiae
S. cerevisiae
S. pombe
Huang et al., 2013b
Svensson et al., 2013
Torres et al., 2013
Pan et al., 2012
Other Acetic acid
Hydrolysate
Neonicotinoids
Manzamine A
NCI diversity/
mechanistic sets
S. cerevisiae
S. cerevisiae
S. cerevisiae
S. cerevisiae
S. cerevisiae/
S. pombe
Sousa et al., 2013
Skerker et al., 2013
Mattiazzi Ušaj et al.,
2013
Kallifatidis et al., 2013
Kapitzky et al., 2010
A literature search identified recently published S. cerevisiae and S. pombe
screens.
advantage of barcoded transposons to extend the yeast DNA bar-
coding methodology to a variety of microorganisms. In essence,
in vitro transposon mutagenesis is utilized to mutagenize a
genomic DNA library, and subsequent transformation of bar-
coded genomic fragments into a compatible unicellular organism
Table 2 | Summary of functional toxicological screens in organisms
other than yeast.
Chemical/condition Organism Methodology References
Clotrimazole C. albicans Deletions Oh et al., 2010a
Wide variety of
growth conditions
and diverse chemical
compounds
C. albicans Deletions Oh et al., 2010b
Paraquat C. elegans RNAi Kim and Sun, 2007
Cell cycle inhibitors D. melanogaster RNAi Eggert et al., 2004
Cell cycle inhibitors D. rerio Morpholinos Murphey et al.,
2006
Various media and
growth inhibitors
E. coli Deletions Warner et al., 2010
Vemurafenib H. sapiens CRISPR Shalem et al., 2014
6-thioguanine H. sapiens CRISPR Wang et al., 2014
Etoposide H. sapiens CRISPR Wang et al., 2014
Wide range of drugs H. sapiens RNAi reviewed by Berns
and Bernards (2012)
Ricin H. sapiens shRNA Bassik et al., 2013
3-bromopyruvate H. sapiens Transposon
mutagenesis
Birsoy et al., 2013
Tunicamycin H. sapiens Transposon
mutagenesis
Reiling et al., 2011
2-amino-6-
mercaptopurine
M. musculus Transposon
mutagenesis
Leeb and Wutz,
2011
6-thioguanine M. musculus Transposon
mutagenesis
Pettitt et al., 2013
Olaparib M. musculus Transposon
mutagenesis
Pettitt et al., 2013
Ricin M. musculus Transposon
mutagenesis
Elling et al., 2011
Wide variety of
growth conditions
and diverse chemical
compounds
S. oneidensis Deletions Deutschbauer
et al., 2011
Minimal media S. oneidensis Deletions Oh et al., 2010a
Plant hydrolysate Z. mobilis Deletions Skerker et al., 2013
A literature search identified published screens.
allows for genome-wide unbiased screening of chemical-genetic
interactions. Akin to the yeast functional process, the barcodes
can be amplified from pooled cultures and counted bymicroarray
hybridization or high-throughput sequencing. Oh et al. (2010a)
demonstrated the versatility of the TagModule collection by gen-
erating tagged mutants in the bacterium Shewanella oneidensis
MR-1 and the fungal pathogen Candida albicans. As a proof
of principle, the authors identified S. oneidensis mutants with
growth deficiencies in minimal media and C. albicans mutants
sensitive to the antifungal drug clotrimazole (Oh et al., 2010a).
The same group reports on additional haploinsufficiency screens
in C. albicans (Oh et al., 2010b) and S. oneidensis (Deutschbauer
et al., 2011) encompassing a wide variety of growth conditions
and diverse chemical compounds. Furthermore, the method was
applied to identify genes important for plant hydrolysate tol-
erance in Zymomonas mobilis, a bacterium with potential for
commercial-scale cellulosic ethanol production (Skerker et al.,
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FIGURE 2 | Overview of functional profiling in yeast. About 4600
deletion strains uniquely identified by DNA sequences (barcodes) are
pooled and exposed to a toxicant at multiple doses and generation times (5
or 15). Barcodes are amplified from purified genomic DNA by PCR and
counted by hybridization to a microarray or high-throughput sequencing
methods. Subsequent analyses of individual strains can confirm
susceptibility or resistance to the toxicant.
2013). By facilitating barcoding of mutant or overexpression
collections for pooled functional analyses in a range of organ-
isms, the TagModule system can be a valuable tool for toxicity
testing.
Alternative approaches utilizing deletion/overexpression
strains, or high-throughput sequencing of tagged transposon
mutants may have applications relevant to functional toxicology.
A signature-tagged mutagenesis strategy permitted parallel
analysis of Cryptococcus neoformans fungal mutants in exper-
imental infections (Liu et al., 2008), while high-throughput
sequencing examined the relative quantities of human gut
bacterium Bacteroides thetaiotaomicron transposon mutants in
wild-type and immunodeficient gnotobiotic mice (Goodman
et al., 2009). Relative strain abundance has been quantified in a
collection of homozygous C. albicans deletion mutants, albeit in a
lower-throughput investigation (Noble et al., 2010) than allowed
by the TagModule system (Oh et al., 2010a). Overexpression
studies can be conducted in C. albicans, however the available
ORFeome is confined to a few hundred genes (Chauvel et al.,
2012). Genome-wide deletion libraries have been constructed in
Escherichia coli (Baba et al., 2006), Bacillus subtilis (Kobayashi
et al., 2003), and Pseudomonas aeruginosa (Jacobs et al., 2003),
with a limited set available in Salmonella enterica (Santiviago
et al., 2009). Thousands of specific genetic modifications were
simultaneously evaluated to quantify population dynamics in
various media and growth inhibitors in E. coli (Warner et al.,
2010). It is conceivable that functional toxicological or even
pharmaceutical inquiries can be performed using any of these
tools and/or organisms.
FUNCTIONAL TOXICOLOGY IN EUKARYOTES OF INCREASED
COMPLEXITY
OVERVIEW
Large-scale targeted deletion collections do not currently exist for
animal models. Published studies are confined to specific subsets
of genes or cellular processes affected by the chemical of interest.
Recent advances in knockout technology maymake genome-wide
functional toxicology possible in complex eukaryotes.
STUDIES IN CELL LINES
Until recently, the DT40 B lymphocyte chicken cell lines, because
of a hyperactive recombination system, represented the only
vertebrate system in which both alleles of a gene could be effi-
ciently disrupted. DT40 cells display a stable phenotype, double
in a short period (∼8 h), and grow in suspension (Yamazoe
et al., 2004; Evans et al., 2010). Thus, DT40 are advantageous
in the functional and mechanistic screening of various toxicants.
Currently, they are used primarily in the study of genotoxicants,
as the majority of the cell lines harbor various individual dele-
tions in DNA repair genes (Ridpath et al., 2007; Yamamoto et al.,
2011; Lee et al., 2013). Although other cellular components and
processes are not represented in the set of mutants, the cells could
become another general resource if additional deletions are gen-
erated. However, because the cells are not barcoded, multiplexing
or parallel growth screens are not possible.
Genome-wide RNA interference (RNAi) screens have become
an important tool in drug discovery (Kiefer et al., 2009), and
can be readily applied to functional toxicological studies. RNAi
methods, first discovered in C. elegans (Fire et al., 1998), exploit
existing cellular machinery to destroy the mRNA of a target gene,
thus preventing translation and effectively “knocking down” the
function of the target gene. RNAi screens in cell lines can be
useful to functional toxicology but are experimentally complex,
as incomplete knockdown of target genes and off-target effects
can complicate execution and analysis (reviewed by North and
Vulpe, 2010). The majority of functional genomic applications in
human cells rely upon RNAi loss-of-function screens (reviewed
by Mullenders and Bernards, 2009). RNAi in Drosophila cell
lines has been previously utilized to study cellular toxicity—as
examples, Eggert et al. (2004) identified small molecules inhibit-
ing the cell cycle, while Zhang et al. (2010) discovered genes
that increased the aggregation of mutant Huntingtin proteins.
Barcoded short hairpin RNA (shRNA—a method to accomplish
RNAi) libraries enable identification of shRNAs that elicit a spe-
cific phenotype under toxicant selection. The relative abundance
of barcodes in control and treated populations can be mea-
sured by hybridization to microarrays (Mullenders and Bernards,
2009) or sequencing (Kimura et al., 2008; Sims et al., 2011). This
method is efficient at detecting shRNAs that increase fitness but
cannot always discover shRNAs that decrease viability, and fur-
thermore, the process is lengthy and requires significant optimiza-
tion (Sims et al., 2011). Nevertheless, RNAi-based screens have
uncovered human genes whose suppression confers resistance to
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a wide range of drugs (reviewed by Berns and Bernards, 2012).
Finally, a two-stage shRNA screen identified mammalian genetic
interactions underlying ricin susceptibility (Bassik et al., 2013).
As noted above, in diploid cells, both chromosomal copies
of the gene of interest must be targeted to fully abrogate gene
function, an inefficient and laborious step wise process. Thus,
an exciting development for the field of functional toxicology is
the identification of haploid mouse (Leeb and Wutz, 2011) and
near haploid human (Carette et al., 2009) cell lines. Transposon
mutagenesis in mouse haploid embryonic stem cells has identi-
fied genes required for resistance to 2-amino-6-mercaptopurine
(Leeb and Wutz, 2011), the chemotherapeutic 6-thioguanine and
the PARP 1/2 inhibitor olaparib (Pettitt et al., 2013), and the
bioweapon ricin (Elling et al., 2011). Similarly, the human cells
are a derivative of a chronic myeloid leukemia cell line haploid
for all chromosomes except chromosome 8. Insertional mutage-
nesis generated null alleles that have been screened for resistance
to host factors used by pathogens (Carette et al., 2009, 2011a; Jae
et al., 2013), the cancer drug candidate 3-bromopyruvate (Birsoy
et al., 2013), and the ER stressor tunicamycin (Reiling et al., 2011).
Especially encouraging is the use of deep sequencing to examine
millions of mutant alleles via selection and sequencing of pools
of cells (Carette et al., 2011b), an improvement over the laborious
analyses of individual clones. These systems promise to advance
chemical-genetic studies in human cell lines.
The toolbox for functional toxicology in mammalian cells is
expanding. The TALE nuclease architecture has been utilized to
regulate mammalian genes and engineer deletions within the
endogenous human NTF3 and CCR5 genes (Miller et al., 2011).
Of particular note is the development of the CRISPR-Cas9 sys-
tem, which may allow for efficient, large-scale, loss of function
screening in mammalian cells (Shalem et al., 2014; Wang et al.,
2014). The strategy utilizes a single guide RNA (sgRNA) to direct
the Cas9 nuclease to cleave target DNA sequences. With lentiviral
delivery of a CRISPR-Cas9 knockout library, sgRNAs serve as dis-
tinct barcodes that can be counted via high-throughput sequenc-
ing to perform negative and positive selection screening in human
cells. One study identified human genes essential for viability
in cancer cells, and also discovered human genes necessary for
survival in vemurafenib, a RAF inhibitor (Shalem et al., 2014).
Others utilized the method in human cell lines to identify genes
required for resistance to the nucleotide analog 6-thioguanine
and the DNA topoisomerase II inhibitor etoposide (Wang et al.,
2014). The simplification and expedition of screening and dele-
tion processes in mammalian cell lines will undoubtedly have
considerable ramifications for functional toxicology.
STUDIES IN WHOLE ORGANISMS
The nematode Caenorhabditis elegans has been exploited in for-
ward genetic and RNAi screens (reviewed by Leung et al., 2008).
Following a round of mutagenesis and selection in a toxicant,
next generation sequencing can identify individual C. elegans
mutants (Doitsidou et al., 2010). Various groups have utilized
limited RNAi screens in nematodes to discover genes that, when
silenced, confer chemical resistance or susceptibility. Examples
include investigations with the herbicide paraquat (Kim and Sun,
2007), whereas gene expression analyses informed RNAi studies
with cadmium (Cui et al., 2007) and PCB-52 (Menzel et al.,
2007). Although many C. elegans homozygous deletion mutants
are available through the Caenorhabditis Genetics Center, high-
throughput methods to assess survival of all strains at once (in
a manner similar to yeast functional profiling) are not avail-
able due to the lack of barcode sequences in the mutants. These
mutants may prove useful in follow-up analyses of conserved
genes and pathways identified by chemical genetic screens in
yeasts or bacteria.
Functional toxicology in more complex whole organisms is
not straightforward, but new technologies offer encouragement
for the future. The zebrafish model is useful in large-scale
in vivo genetic and chemical studies (Pardo-Martin et al., 2010).
Forward chemical genetic screens in zebrafish have identified
small molecules inhibiting the cell cycle (Murphey et al., 2006)
and examined genes involved in copper-dependent hypopigmen-
tation (Ishizaki et al., 2010). An emerging multidimensional
high-throughput in vivo approach in embryonic zebrafish, where
a wide variety of developmental morphology and neurotoxicity
endpoints are rapidly screened to understand chemical toxicity
(Truong et al., 2014), indicates that the field of toxicology is
advancing in the study of whole organisms. Combining this type
of screening strategy with other methodologies such as RNAi,
although not currently performed on a large scale basis, could
provide additional information related to chemical mechanisms
of toxicity.
Traditional approaches for generation of knockout animals in
mice remains a time-consuming and costly process that limits its
utility in functional toxicology to confirmatory analysis.
However, new systems facilitating deletions in animals can be
used to selectively target genes for editing or mutagenesis (Miller
et al., 2011; Wilkinson and Wiedenheft, 2014). For example, the
site-specific endonuclease TALE-nuclease was used to mediate
mutagenesis in mouse zygotes, producing animals with genetic
knockouts of the progesterone immunomodulatory binding fac-
tor 1 and selenoprotein W, muscle 1 (Sung et al., 2013). The
European ConditionalMouseMutagenesis program (EUCOMM)
and the Knockout Mouse Project (KOMP) are two large-scale
mouse phenotyping initiatives that aim to provide libraries of
knockout animals for further study (Ayadi et al., 2012). The focus
of these efforts, however, has been on phenotypic analysis of the
mutants rather than the intersection between chemical exposure
and genetic background. Knockouts created by these methodolo-
gies could expedite analyses of conserved toxicant mechanisms in
a variety of animal models. At the present, however, more reason-
able is the use of individual animal knockouts or knockdowns to
confirm results acquired in less complex systems such as yeast.
APPLICATION OF COMPUTATIONAL ANALYSES TO
FUNCTIONAL TOXICOLOGY
Inherent in high-throughput functional toxicologymethods is the
use of computational analyses to decipher toxicantmechanisms of
action. Various studies have utilized overenrichment or Cytoscape
software (Shannon et al., 2003) to uncover yeast genetic net-
works affected by a toxicant (Zhou et al., 2009; North et al., 2011;
Gaytán et al., 2013a,b; Kaiser et al., 2013). Others, by integrat-
ing data from many distinct yeast chemical-genetic datasets, have
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FIGURE 3 | Integration of functional assays across organisms. One can
use functional tools across a variety of organisms, depending upon the model
under study and the end goal of the investigation. For example, one may start
with a screen in yeast, mouse, or human cells and extend the analyses to
whole organisms such as zebrafish or rodents. Alternatively, one may start
with zebrafish mutants or DT40 avian deletion cells and perform follow-up
experimentation in human cells or other whole organisms. The many
possibilities can advance the future of toxicity testing.
assembled chemical-phenotype networks that helped identify
potential effects elicited by various compounds (Venancio et al.,
2010). Without computational analyses, the high-throughput
approaches in zebrafish (Truong et al., 2014) or human cell lines
(Shalem et al., 2014) would not be possible.
CHALLENGES WITH FUNCTIONAL TOXICOLOGY
For a variety of reasons, functional toxicology has its limitations
in the range of organisms discussed within this review. Less com-
plex organisms such as yeasts, other fungi, and bacteria possess
P450 enzymes (Käppeli, 1986; Urlacher et al., 2004; McLean et al.,
2005), but their role in toxicant metabolism is limited. To better
understand chemical toxicity to humans, toxicant activation or
deactivation may be catalyzed in these experiments by adding S-9
human liver microsomes. Additionally, in unicellular organisms,
cell lines, and less complex eukaryotes such as C. elegans, one is
unable to examine a toxicant’s target organs or systemic effects.
The discovery of human disease models through orthologous
phenotypes may address these concerns. For example, McGary
et al. (2010) proposed a yeast model for angiogenesis defects and
a C. elegansmodel for breast cancer, based upon analyses of genes
shared between the model system and an organism displaying the
disease under study. Similar analyses of functional data from uni-
cellular organisms, cell lines, and C. elegans may reveal toxicant
mechanisms associated with more complex biological processes.
In whole organisms, throughput is the major barrier to
progress in functional toxicology. In yeasts and bacteria, bar-
coded systems allow for the high-throughput examination of
thousands of deletion mutants in parallel (Giaever et al., 2002;
Oh et al., 2010a). The lack of such methods in whole organisms
such as zebrafish or rodent models diminishes throughput, and
complicates systematic identification of genes required for resis-
tance to a toxicant. Until high-throughput screens are devised
in whole organisms, such systems are invaluable in extending or
confirming results gathered in yeasts or bacteria.
THE FUTURE OF FUNCTIONAL TOXICOLOGY
Functional toxicological screening methods, i.e., those that iden-
tify genetic requirements for chemical tolerance, are powerful,
unbiased tools which provide unique mechanistic insights in
the field of toxicology. High-throughput screens of chemicals
of concern or unknown toxicity will allow toxicologists to for-
mulate hypotheses related to their corresponding mechanisms
and pathways of toxicity. Automation and deep parallel sequenc-
ing technologies will unquestionably increase the throughput of
functional techniques, but extensive computational resources and
knowledge will be required to implement screening systems and
analyze the resulting data. Integration of functional assays across
a variety of organisms can identify conserved modes of toxicity
and direct studies most relevant to human health (Figure 3). The
field of functional toxicology is primed to assist toxicologists meet
the need for enhanced chemical toxicity testing.
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